Methotrexate in a Real-World Psoriasis Treatment: Is It Really a Dangerous Medication for All?

참고문헌 (10)

1. Edmundson WF, "Treatment of psoriasis with folic acid antagonists", AMA Arch Derm, 78, pp.200~203 (1958)
2. Heydendael VM, "Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis", N Engl J Med, 349, pp.658~665 (2003)
3. Haustein UF, "Methotrexate in psoriasis: 26 years’experience with low-dose long-term treatment", J Eur Acad Dermatol Venereol, 14, pp.382~388 (2000)
4. Weidmann A, "Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature", Dermatol Ther (Heidelb), 4, pp.145~156 (2014)
5. Salliot C, "Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research", Ann Rheum Dis, 68, pp.1100~1104 (2009)
6. Kivity S, "Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients", Autoimmun Rev, 13, pp.1109~1113 (2014)
7. Kalb RE, "Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference", J Am Acad Dermatol, 60, pp.824~837 (2009)
8. Weinstein GD, "An approach to the treatment of moderate to severe psoriasis with rotational therapy", J Am Acad Dermatol, 28, pp.454~459 (1993)
9. Pathirana D, "European S3-guidelines on the systemic treatment of psoriasis vulgaris", J Eur Acad Dermatol Venereol, (23Suppl 2), pp.1~70 (2009)
10. Maybury CM, "Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies", Br J Dermatol, 171, pp.17~29 (2014)

관련 논문AI추천